---
tags:
  - medicine
  - rheumatology
edited: 2024-01-25
---
### Etiology
- 

### Pathogenesis
- Can involve all systems
	- 

### Types
- Limited cutaneous SC; previously called [[CREST syndrome]] 
- Diffuse: CREST syndrome + HULK 
	- Systemic or pulmonary hypertension
	- [[Coronary Artery Disease]] 
	- [[Pulmonary fibrosis]] and restrictive pattern 
	- [[Glomerulonephritis]] which worsens HTN
	- [[Scleroderma renal crisis]] 

### Diagnostics
- Complete blood count and differential, which may reveal anemia due to malabsorption, iron deficiency, or gastrointestinal blood loss
- Serum creatinine level, which may indicate renal dysfunction
- Creatine kinase (CK), which may be elevated in patients with myopathy or myositis
- Urinalysis with urine sediment, which may reveal proteinuria and/or cellular casts
#### Antibodies
- ANA: Non-specific 
- Anti-centromere: Limited cutaneous
- Anti-Scl-70 (topoisomerase-1) Ab:  Diffuse cutaneous SSc
- Anti-RNA polymerase III Ab: dcSSc
- [[Nailfold capillaroscopy]]: Abnormal capillaries, avascular areas, micro-hemorrhages (secondary Raynaud phenomenon as seen in SS)
- Diagnostic criteria (ACR/EULAR) 

### Management
- Multidisciplinary
- Steroids and immunosuppressants 
	- Methotrexate or Mycophenolate
	- resistant disease, we suggest intravenous immunoglobulin (IVIG), rituximab, or tocilizumab
	- reserve cyclophosphamide for progressive skin involvement in patients who are refractory to treatment with either MTX or MMF or who have severe rapidly progressive skin thickening
- Non-medical
	- Avoid smoking
	- Gentle stretching
	- Avoid cold
	- Emollients
	- Physiotherapy
	- For refractory pruritus, we suggest a short course of low-dose oral glucocorticoids
- Medical:
	- Nifedipine
	- Antacids
	- Metoclopramide
	- Analgesics for joint pain
	- Antibiotics
	- Anti-hypertensives ACE inhibitors

| Condition                      | Treatment Recommendations                                                                                                                                                                                                                                                                                                                                                                                                                      |
| ------------------------------ | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Diffuse Skin Sclerosis         | -**Initial Treatmen**t: Methotrexate (MTX) or Mycophenolate Mofetil (MMF) <br>-**Resistant Disease**: Intravenous Immunoglobulin (IVIG), Rituximab, Tocilizumab <br>- **Reserved** for Severe Rapidly Progressive Skin Thickening: Cyclophosphamide                                                                                                                                                                                            |
| Other Cutaneous Manifestations | - **Pruritus**: Topical Emollients (e.g., lanolin), <br>Counterirritants (e.g., topical capsaicin, menthol), <br>Antihistamines (e.g., hydroxyzine, diphenhydramine) <br>- **Refractory Pruritus**: Short Course of Low-dose Oral Glucocorticoids <br>- **Telangiectasias**: Laser Therapy <br>- **Calcinosis Cutis**: Minocycline; **Refractory Cases**: MTX, Infliximab, Rituximab; <br>Surgical Removal for Significant Pain and Disability |


---
### *Related
- 